Qube Research & Technologies LTD Ironwood Pharmaceuticals Inc Transaction History

Qube Research & Technologies LTD

$82.3 Billion
Q1 2025

A detailed history of Qube Research & Technologies LTD transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 3,307,059 shares of IRWD stock, worth $2.98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,307,059

Previous 257,730 1183.15%

Holding current value

$2.98 Million

Previous $1.14 Million 326.03%

% of portfolio

0.01%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.41 - $4.58 $4.3 Million - $14 Million	3,049,329 Added 1183.15%	3,307,059 $4.86 Million
Q4 2024 Feb 14, 2025	SELL	$3.34 - $5.04 $1.05 Million - $1.58 Million	-313,045 Reduced 54.85%	257,730 $1.14 Million
Q3 2024 Nov 14, 2024	BUY	$3.93 - $7.04 $2.24 Million - $4.02 Million	570,775 New	570,775 $2.35 Million
Q4 2023 Feb 13, 2024	BUY	$8.79 - $11.51 $695,886 - $911,223	79,168 New	79,168 $905,000
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $525,200 - $603,200	52,000 Added 25.21%	258,308 $2.75 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $373,465 - $452,335	36,014 Added 21.15%	206,308 $2.17 Million
Q4 2022 Feb 14, 2023	BUY	$9.9 - $12.43 $363,953 - $456,964	36,763 Added 27.53%	170,294 $2.11 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $136,829 - $167,055	-13,494 Reduced 9.18%	133,531 $1.38 Million
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $1 Million - $1.16 Million	90,885 Added 161.89%	147,025 $1.7 Million
Q1 2022 May 09, 2022	SELL	$10.61 - $12.88 $1.07 Million - $1.3 Million	-100,655 Reduced 64.2%	56,140 $706,000
Q4 2021 Feb 01, 2022	BUY	$10.86 - $13.95 $958,872 - $1.23 Million	88,294 Added 128.89%	156,795 $1.83 Million
Q3 2021 Nov 12, 2021	BUY	$11.92 - $13.92 $816,531 - $953,533	68,501 New	68,501 $895,000
Q1 2021 May 14, 2021	SELL	$9.04 - $11.86 $628,569 - $824,649	-69,532 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $629,264 - $848,290	69,532 New	69,532 $792,000
Q3 2020 Nov 12, 2020	SELL	$8.99 - $10.74 $489,999 - $585,383	-54,505 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $350,162 - $458,582	38,311 Added 236.58%	54,505 $562,000
Q1 2020 May 15, 2020	BUY	$8.58 - $14.01 $33,727 - $55,073	3,931 Added 32.06%	16,194 $163,000
Q4 2019 Feb 13, 2020	BUY	$8.22 - $14.0 $100,801 - $171,682	12,263 New	12,263 $163,000

Others Institutions Holding IRWD

# of Institutions

208

Shares Held

171M

Call Options Held

11.2M

Put Options Held

6.9K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $138M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Ironwood Pharmaceuticals Inc Transaction History